EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.


Gumus M., Geredeli C., Ucar M., Kaya S., Demir H., Unal O. U. , ...Daha Fazla

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35 identifier